Concepedia

Nathan L. Absalom

NL

Statistics

Publications

31

Citations

1.3K

H-Index

20

Active since

2003

Affiliations

The University of Sydney(Current)

University of Copenhagen

UNSW Sydney

University of Southern Denmark

Western Sydney University

Nathan L. Absalom is an author at The University of Sydney specializing in neuropharmacology, pharmacology, and neuroscience.

ORCID

Publications per year

2003–2024

31

Publications

31

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions

Lyndsey L. Anderson, Nathan L. Absalom, Sarah V. Abelev et al. · Epilepsia · 2019 · 156 citations · Full text

, , +15

α4βδ GABA <sub>A</sub> receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)

Nathan L. Absalom, Laura F. Eghorn, Inge S. Villumsen et al. · Proceedings of the National Academy of Sciences · 2012 · 96 citations · Full text

, , +17

Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism

Han Chow Chua, Emilie T. H. Christensen, Kirsten Hoestgaard-Jensen et al. · PLoS ONE · 2016 · 84 citations · Full text

, , +17

Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies

Nathan L. Absalom, Vivian W. Y. Liao, Katrine M. Johannesen et al. · Nature Communications · 2022 · 83 citations · Full text

, , +17

Role of Charged Residues in Coupling Ligand Binding and Channel Activation in the Extracellular Domain of the Glycine Receptor

Nathan L. Absalom, T. Lewis, Warren Kaplan et al. · Journal of Biological Chemistry · 2003 · 78 citations · Full text

, , +17

1–5 of 31